Tremelimumab

Drugs in R and D - United Kingdom
doi 10.2165/11584530-000000000-00000
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors

Unknown

Publisher

Springer Science and Business Media LLC

Related search

Tremelimumab-Induced Graves Hyperthyroidism

European Thyroid Journal
EndocrinologyMetabolismDiabetes
2017English

A Phase II Trial of Tremelimumab (CP-675,206) in Patients With Advanced Refractory or Relapsed Melanoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

ARCTIC: Durvalumab With or Without Tremelimumab as Third-Line or Later Treatment for Metastatic Non-Small Cell Lung Cancer

Annals of Oncology
MedicineOncologyHematology
2020English

Exposure‐response Analysis of Overall Survival for Tremelimumab in Unresectable Malignant Mesothelioma: The Confounding Effect of Disease Status

Clinical and Translational Science
GeneticsMolecular BiologyPharmacologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2019English

P1.01-52 BR-34- Randomized Trial of Durvalumab and Tremelimumab +/- Platinum Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Case Report of Drug-Induced Myopathy Involving Extraocular Muscles After Combination Therapy With Tremelimumab and Durvalumab for Non-Small Cell Lung Cancer

Neuro-Ophthalmology
OphthalmologyNeurology
2017English

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of Tremelimumab for Second and Third Line Treatment in Patients With Unresectable Pleural or Peritoneal Mesothelioma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

192TiP: NEPTUNE: A Global, Phase 3 Study of Durvalumab (MEDI4736) Plus Tremelimumab Combination Therapy Versus Standard of Care (SoC) Platinum-Based Chemotherapy in the First-Line Treatment of Patients (Pts) With Advanced or Metastatic NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy